Trial Profile
Validation of Instruments for Pragmatic Clinical Trials for Overactive Bladder
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 May 2015
Price :
$35
*
At a glance
- Drugs Fesoterodine (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms PfizerOABLUT
- 08 May 2015 New trial record